Illinois Finance Authority Resurrection Health Care Corp.; Joint Criteria; System Nov 09

  • ID: 1723718
  • November 2009
  • Region: Illinois
  • Standard & Poors
1 of 3

Standard & Poor's Ratings Services assigned its 'BBB+' long-term rating on Illinois Finance Authority's $112.7 million series 2009 revenue refunding bonds issued on behalf of Resurrection Health Care Corp. and its affiliates (RHC). Standard & Poor's also affirmed its 'BBB+' long-term rating and underlying rating (SPUR) on the authority's existing debt and its 'AAA/A-1+' joint-criteria rating on the authority's series 2005B and 2008B bonds and 'AA+/A-1' joint-criteria rating on the authority's series 2005C and 2008A bonds. The outlook on the unenhanced rating and SPUR on RHC remains negative. The 'AAA' component of the joint-criteria rating on the series 2005B and 2008B bonds is based jointly on the obligor and the letters of credit (LOCs) provided by JP Morgan Chase Bank...

Companies mentioned in this report are:
- Illinois Fin Auth

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

- Illinois Fin Auth

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.